Literature DB >> 24629905

[Aplastic crisis due to parvovirus B19 and Epstein-Barr virus in a patient with hereditary spherocytosis].

I Leoz Gordillo1, E Pérez Suárez2.   

Abstract

Anemic syndrome in childhood requires a diagnosis and urgent treatment guided by systematic protocols that can avoid unnecessary additional testing. The case of a 4 year-old girl with fatigue and intermittent fever of 7 days duration, accompanied by abdominal pain is presented. She had regular general health status, with mucocutaneous jaundice, a grade III/VI/iv murmur, and painful abdomen with hepatosplenomegaly. The blood analysis showed a hypo-regenerative anemia with increased LDH and indirect bilirubin. The Coombs Test was negative, with spherocytes being observed in the peripheral blood smear. The IgM and IgG were positive for parvovirus B19 IgM and Epstein Barr virus, leading to the diagnosis of aplastic crisis in a patient with hereditary spherocytosis. No specific treatment was required. Under the suspicion of anemic syndrome in emergencies, the ABCDE sequence must be followed. Through the history, physical examination and basic laboratory tests, an initial diagnostic approach can be made. Specific etiological tests should be based on this first study.
Copyright © 2013 Asociación Española de Pediatría. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Anemia hemolítica; Aplastic crisis; Crisis aplásica; Epstein-Barr virus; Esferocitosis hereditaria; Hemolytic anemia; Hereditary spherocytosis; Parvovirus B19; Virus de Epstein-Barr

Mesh:

Year:  2014        PMID: 24629905     DOI: 10.1016/j.anpedi.2013.12.014

Source DB:  PubMed          Journal:  An Pediatr (Barc)        ISSN: 1695-4033            Impact factor:   1.500


  1 in total

1.  Acute arrest of hematopoiesis induced by infection with Staphylococcus epidermidis following total knee arthroplasty: A case report and literature review.

Authors:  Lintao Bi; Jun Li; Zhenxia Lu; Hui Shao; Ying Wang
Journal:  Exp Ther Med       Date:  2016-01-25       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.